NCT00599404View on ClinicalTrials.gov

PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

PN400

500 mg esomeprazole/20 mg naproxen, once daily on Days 1-10 and twice daily on Days 2-9

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00599404 - PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400 | Biotech Hunter | Biotech Hunter